Lv2
190 积分 2023-03-06 加入
Dual PI3K/mTOR inhibition is required to combat resistance to CDK4/6 inhibitor and endocrine therapy in PIK3CA -mutant breast cancer
2天前
已完结
Enantioselective Synthesis of Chromenes via a Palladium‐Catalyzed Asymmetric Redox‐Relay Heck Reaction
14天前
已完结
Bruton Tyrosine Kinase Degraders
1个月前
已完结
Beyond Ozempic: brand-new obesity drugs will be cheaper and more effective
2个月前
已完结
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
2个月前
已完结
Route Development toward a Pyrazine Building Block to Enable Early Scale-Up Campaigns
2个月前
已完结
Etripamil Nasal Spray: Therapeutic Potential for Treating Paroxysmal Supraventricular Tachycardia
2个月前
已关闭
Innovative pharmacological approaches to hypertrophic cardiomyopathy: The emerging role of Aficamten
3个月前
已完结
How common is hypertrophic cardiomyopathy… really?: Disease prevalence revisited 27 years after CARDIA
3个月前
已完结
Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors
3个月前
已完结
皖公网安备34019202002308
